Kezar Life Sciences, Inc. announced that on April 21, 2023, Christopher Kirk, Ph.D. resigned from his role as President and Chief Scientific Officer of athe company. Dr. Kirk remains a member of the Board of Directors of the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.66 USD | -0.60% | -6.68% | -30.21% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.21% | 48.34M | |
+15.28% | 122B | |
+18.50% | 113B | |
+3.61% | 22.66B | |
-18.97% | 21.34B | |
-41.55% | 16.92B | |
-14.65% | 16.68B | |
-16.03% | 16.61B | |
+0.46% | 13.62B | |
+22.78% | 11.04B |
- Stock Market
- Equities
- KZR Stock
- News Kezar Life Sciences, Inc.
- Kezar Life Sciences, Inc. Announces Resignation of Christopher Kirk as President and Chief Scientific Officer